RNA interference tolerates 2'-fluoro modifications at the Argonaute2 cleavage site.

Chem Biodivers 2007 May;4(5):858-73

Bone Biology Research Consortium, Institute of Biomedicine, Department of Anatomy, University of Turku.

Short interfering RNA (siRNA) molecules with good gene-silencing properties are needed for drug development based on RNA interference (RNAi). An initial step in RNAi is the activation of the RNA-induced silencing complex RISC, which requires degradation of the sense strand of the siRNA duplex. Although various chemical modifications have been introduced to the antisense strand, modifications to the Argonaute2 (Ago2) cleavage site in the sense strand have, so far, not been described in detail. In this work, novel 2'-F-purine modifications were introduced to siRNAs, and their biological efficacies were tested in cells stably expressing human tartrate-resistant acid phosphatase (TRACP). A validated siRNA that contains both purine and pyrimidine nucleotides at the putative Ago2 cleavage site was chemically modified to contain all possible combinations of 2'-fluorinated 2'-deoxypurines and/or 2'-deoxypyrimidines in the antisense and/or sense strands. The capacity of 2'-F-modified siRNAs to knock down their target mRNA and protein was studied, together with monitoring siRNA toxicity. All 2'-F-modified siRNAs resulted in target knockdown at nanomolar concentrations, despite their high thermal stability. These experiments provide the first evidence that RISC activation not only allows 2'-F modifications at the sense-strand cleavage site, but also increase the biological efficacy of modified siRNAs in vitro.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbdv.200790073DOI Listing
May 2007
3 Reads

Publication Analysis

Top Keywords

cleavage site
16
ago2 cleavage
8
modifications argonaute2
8
2'-f-modified sirnas
8
sense strand
8
modifications introduced
8
rna interference
8
modifications
5
despite high
4
tested cells
4
efficacies tested
4
biological efficacies
4
sirnas biological
4
high thermal
4
cells stably
4
stably expressing
4
tartrate-resistant acid
4
nanomolar concentrations
4
introduced sirnas
4
expressing human
4

Altmetric Statistics

References

(Supplied by CrossRef)

Denli et al.
Trends Biochem. Sci. 2003

Bernstein et al.
Nature 2001

Elbashir et al.
EMBO J. 2001

Stark et al.
Annu. Rev. Biochem. 1998

Nykänen et al.
Cell 2001

Leuschner et al.
EMBO Rep. 2006

Rand et al.
Cell 2005

Parker et al.
Nature 2005

Ma et al.
Nature 2005

Pham et al.
Cell 2004

Tomari et al.
Science 2004

Similar Publications